Your browser doesn't support javascript.
loading
A health state utility valuation study to assess the impact of treatment mode of administration in Gaucher disease.
Hadi, Monica; Swinburn, Paul; Nalysnyk, Luba; Hamed, Alaa; Mehta, Atul.
Affiliation
  • Hadi M; Patient-Centered Outcomes, Mapi, London, UK.
  • Swinburn P; Patient-Centered Outcomes, Mapi, London, UK.
  • Nalysnyk L; Sanofi Genzyme, 50 Binney Street, Cambridge, MA, 02142, USA. lubomyra.nalysnyk@sanofi.com.
  • Hamed A; Sanofi Genzyme, 50 Binney Street, Cambridge, MA, 02142, USA.
  • Mehta A; Lysosomal Storage Disorders Unit, Department of Haematology, Royal Free Hospital and University College Medical School, London, UK.
Orphanet J Rare Dis ; 13(1): 159, 2018 09 10.
Article in En | MEDLINE | ID: mdl-30201003
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gaucher Disease Type of study: Qualitative_research Aspects: Patient_preference Limits: Adult / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Orphanet J Rare Dis Journal subject: MEDICINA Year: 2018 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gaucher Disease Type of study: Qualitative_research Aspects: Patient_preference Limits: Adult / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Orphanet J Rare Dis Journal subject: MEDICINA Year: 2018 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom